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Abstract Interferon-Q (IFN-Q) induces growth arrest and
apoptosis of tumor cells but the mechanisms for these functions
are unknown. Recently, gut-enriched kru«ppel-like factor (GKLF)
was found to possess similar biological properties. Treatment of
HT-29 cells with IFN-Q inhibited cell proliferation and induced
apoptosis, the effect was found to associate with GKLF
expression. IFN-Q stimulates GKLF mRNA and protein levels
in a dose- and time-dependent manner and this process is
independent of p53, occurs rapidly and does not require de novo
protein synthesis indicating that GKLF is an immediate-early
IFN-Q-responsive gene. Moreover, overexpression of GKLF
results in similar effect as IFN-Q suggesting that GKLF may
function as a downstream target of IFN-Q. ß 2000 Federation
of European Biochemical Societies. Published by Elsevier Sci-
ence B.V. All rights reserved.
Key words: Gut-enriched kru«ppel-like factor; Apoptosis;
Growth arrest ; HT-29 cell ; p53
1. Introduction
Interferons (IFNs), including type I (IFN-K and -L) and
type II (IFN-Q), are a family of cytokines with diverse biolog-
ical functions, including antiviral, antiproliferative and immu-
nomodulatory e¡ects [1^6]. It has been postulated that IFNs
exert their biological activities by inducing the expression of a
number of e¡ector genes (IFN-inducible genes or IFN-Q-re-
sponse genes) on the target cell, and that these e¡ects are
modulated largely at the transcriptional level [7,8]. It has
also been suggested that the intracellular signaling pathway
triggered by the activation of IFNs receptors involved phos-
phorylation of Janus kinase (JAK), and signal transducer and
activator of transcription (STAT) by tyrosine kinase [9,10].
Previous studies have demonstrated that IFN-Q inhibits cell
growth and induces apoptosis in several tumor cells [11,12].
However, the mechanisms mediating its action are not fully
understood. It has been reported that IFN-Q induces the ex-
pression of p21WAF1=CIP1, a repressor of cyclin-dependent ki-
nase, and inhibits cell growth by blocking the cell cycle pro-
gression [11]. In addition, Xu et al. showed that IFN-Q up-
regulates the expression of Fas and Fas ligand (FasL) on HT-
29 cells and subsequently induces apoptosis of these cells [12].
They suggested that the growth inhibitory e¡ect of IFN-Q is
due to Fas- and FasL-mediated apoptosis. More recently,
Chin et al. demonstrated that the activation of the STAT
pathway is critical for IFN-Q-induced apoptosis [13]. Togeth-
er, these data suggest that IFN-Q may induce growth arrest
through multiple mediators.
Gut-enriched kru«ppel-like factor (GKLF) is a newly iden-
ti¢ed eukaryotic zinc ¢nger transcription factor [14,15]. The
amino acid sequence of the zinc ¢nger portion of GKLF is
closely related to other kru«ppel proteins, including the lung
kru«ppel-like factor, and the erythroid kru«ppel-like factor, and
the basic transcription element binding protein 2 [16,17]. The
GKLF mRNA levels in NIH 3T3 ¢broblasts were found to be
increased during growth arrest by serum deprivation or con-
tact inhibition [14]. Our laboratory has recently shown that
GKLF expression was down-regulated in the dysplastic colon-
ic epithelium suggesting that GKLF might be an important
factor in controlling cell growth [18]. Furthermore, proin£am-
matory cytokines, particularly IFN-Q, have been shown to be
up-regulated in patients with in£ammatory bowel diseases in
which active cellular turn-over occurs [19]. Whether GKLF is
a potential downstream target of IFN-Q has not been inves-
tigated. In the present report, we demonstrate that GKLF
mRNA expression in HT-29 cells was induced by IFN-Q,
and that this induction is associated with IFN-Q-promoted
growth inhibition and programmed cell death. Furthermore,
up-regulation of GKLF expression by IFN-Q is time- and
dose-dependent, and does not depend on p53 and de novo
protein synthesis. This is the ¢rst report suggesting that
GKLF is one of the target genes of IFN-Q.
2. Materials and methods
2.1. Cell culture and IFN-Q treatment
The human colon carcinoma cell line (HT-29) was obtained from
the American Type Tissue Culture Collection (ATCC, Rockville,
MD). Two additional human colon carcinoma cell lines, 40-16
(HCT116, p53+/+) and 379.2 (HCT116, p533/3), were kindly pro-
vided by Dr. Bert Vogelstein (Johns Hopkins University). These cells
were cultured in modi¢ed McCoy’s 5A medium containing 10% fetal
bovine serum, penicillin and streptomycin, in an atmosphere of 95%
air and 5% carbon dioxide at 37‡C. Cells were subcultured at appro-
priate intervals to maintain subcon£uent growth conditions. Human
recombinant IFN-Q was purchased from Boehringer Mannheim (In-
dianapolis, IN), and used at a ¢nal concentration of 200 U/ml unless
stated otherwise. IFN-Q treatments were performed by replacing the
media with fresh complete medium with or without IFN and cells
were harvested at appropriate time points for analysis. Human re-
combinant IFN-K and IFN-L were obtained from from Boehringer
Mannheim (Indianapolis, IN).
2.2. Cell transfection
Transient transfection was performed by the lipofection method
using the lipofectin reagent as recommended by the manufacturer
(Life Technologies, Inc.). Transfections of 40-16 (HCT116, p53+/+)
and 379.2 (HCT116, p533/3) cells were accomplished using 2 Wg/well
pcDNA3 or pcDNA3-GKLF DNA in six-well plates. Two days fol-
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lowing transfection, cells were examined for speci¢c protein expression
by Western blot analysis.
2.3. Measurement of cell proliferation
Cell number was determined using a semi-automated tetrazolium-
based colorimetric (MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylte-
trazolium bromide) assay as described previously [20]. Brie£y, HT-29
cells were seeded into a 24-well plate at a density of 5U104 cells/well
and incubated overnight at 37‡C. Cells were treated with IFN-Q for
24 h and at the end of treatment, 20 Wl of MTT (2.5 mg/ml) was
added to each well. Cells were incubated for an additional 4 h to
allow the interaction between dye and mitochondrial dehydrogenase
in the viable cells. After removal of the residual dye and medium,
500 Wl of dimethylsulfoxide was added, and the absorbance at
540 nm was measured with a spectrophotometer.
2.4. Detection of DNA fragmentation
For analysis of DNA fragmentation, control and IFN-Q-treated
cells were collected by centrifugation. Low molecular weight genomic
DNA was extracted as described in [21]. Brie£y, the washed cells were
lysed in a solution of 10 mM Tris^HCl, pH 8.0, 10 mM EDTA, and
0.5% Triton X-100. Samples were mixed and then centrifuged at
13 000Ug for 10 min. The supernatant containing low molecular
weight DNA was recovered and extracted twice with equal volumes
of phenol:chloroform:isoamyl alcohol (25:24:1, v/v). DNA was pre-
cipitated in 0.3 M sodium acetate and two volumes of cold (320‡C)
ethanol overnight. The pellets were resuspended in TE bu¡er contain-
ing 100 ng of DNase-free RNase and incubated for 30 min at room
temperature before being subjected to electrophoresis in 2% agarose
gels. DNA was visualized by ethidium bromide staining. Gels were
photographed using a Polaroid camera with 667 ¢lm.
2.5. RNA isolation and Northern blot analysis
Total RNA was isolated by the STAT-601 method following the
manufacturer’s instructions (Leedo Medical Laboratories, Inc., Hous-
ton, TX). RNA samples (20 Wg) were denatured, size fractionated by
electrophoresis in 1.2% agarose-formaldehyde gel, and transferred
onto Zetabind nylon membranes (Cuno, Inc., Meriden, CT). Hybrid-
ization was performed at 42‡C overnight using [K-32P]dCTP-labeled
GKLF probe (Random primer labeling kit from Boehringer Mann-
heim, Indianapolis, IN). Blots were washed with 2USSPE/0.1% SDS,
followed by 0.1USSPE/0.1% SDS. All blots were stripped and re-
probed with glyceraldehyde-3-phosphate dehydrogenase cDNA probe
(GAPDH; Clontech, Palo Alto, CA) to correct for RNA loading.
2.6. Western blot analysis
To obtain whole-cell extracts, cells were washed twice with ice-cold
phosphate-bu¡ered saline, scraped, and pelleted by centrifugation
(200Ug). Cell pellets were then lysed in the standard RIPA bu¡er
(50 mM Tris^HCl, pH 7.5, 150 mM NaCl, 1.0% NP-40, 0.5% sodium
deoxycholate, and 0.1% SDS) containing protease inhibitors. Protein
concentrations were determined by Bio-Rad assays and 25^80 Wg of
protein from each sample was separated on the 10% SDS^polyacryl-
amide gel. Following electrophoresis, the proteins were transferred to
nitrocellulose membranes (Bio-Rad) at 100 V for 1.5 h at 4‡C. Poly-
clonal antibody to GKLF was used at 1:500 dilution, and the DO-1
p53 monoclonal antibody (Santa Cruz Biotechnology, Santa Cruz,
CA) was used at 1:1000 dilution. Speci¢c protein was detected using
horseradish peroxidase-conjugated secondary antibodies and en-
hanced chemiluminescence (ECL) following the manufacturer’s in-
struction (Amersham, Arlington Heights, IL).
2.7. Statistics
Results are expressed as mean þ S.E.M. Statistical analysis was per-
formed using ANOVA and Student’s t-test. P values less than 0.05
were considered to be statistically signi¢cant.
3. Results
3.1. IFN-Q-induced growth inhibition and programmed cell
death are correlated with up-regulation of GKLF
expression in HT-29 cells
The e¡ect of IFN-Q on the growth of HT-29 cells was ex-
amined using the MTT assay. As shown in Fig. 1A, IFN-Q
inhibited cell growth in a dose-dependent manner with signi¢-
cant inhibition observed at 20 and 200 U/ml. To examine
whether the growth inhibitory e¡ect of IFN-Q is associated
with apoptosis of HT-29 cells, DNA fragmentation analysis
was performed. As shown in Fig. 1B, at concentrations of 20
or 200 U/ml, IFN-Q was capable of inducing DNA fragmen-
tation in HT-29 cells. In contrast, no fragmented DNA was
observed in untreated control cells. These results are consis-
tent with previous reports indicating that IFN-Q treatment
induces growth arrest and apoptosis of HT-29 cells.
To explore whether GKLF is involved in the IFN-Q-induced
growth arrest and apoptosis, GKLF mRNA levels were ex-
amined in IFN-Q-treated or untreated HT-29 cells by North-
ern blot analysis. As shown in Fig. 2, GKLF mRNA levels
were induced dose-dependently by IFN-Q treatment (Fig. 2A),
and these increments were also time-dependent, with the most
signi¢cant increase observed at 24 h after treatment (Fig. 2B).
Moreover, the induction of GKLF mRNA expression was
associated with increases in GKLF protein levels (Fig. 2C).
These data suggest that GKLF is an IFN-Q-inducible gene,
and may play a role in IFN-Q-promoted growth arrest and
programmed cell death in HT-29 cells.
Fig. 1. IFN-Q induces growth inhibition and apoptosis of HT-29
cells in a dose-dependent manner. A: HT-29 cells were treated with
di¡erent concentrations of IFN-Q for 24 h and cell growth was mea-
sured using the MTT assay as described in Section 2. Each data
point represents the mean þ S.E.M. of three separate experiments
and was expressed as optimal density (OD). *P6 0.05 vs. control
(dose = 0). B: Low molecular weight genomic DNA extracted from
IFN-Q-treated HT-29 cells was analyzed by agarose gel electrophore-
sis and DNA fragmentation was visualized by ethidium bromide
staining.
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3.2. GKLF expression induced by IFN-Q is independent of p53
Although p53 protein has been shown to regulate the ex-
pression of several transcription factors, the p53 gene in HT-
29 cells was known to be mutated. To determine whether the
induction of GKLF expression by IFN-Q is mediated through
p53, two human colonic adenocarcinoma cells, 40-16
(HCT116, p53+/+; possessing wild-type p53) and 379.2
(HCT116, p533/3 ; a p53-de¢cient mutant), were used for
the studies. As demonstrated in Fig. 3, IFN-Q increased
GKLF mRNA levels in a dose-dependent manner in both
40-16 and 379.2 cells suggesting that IFN-Q-mediated GKLF
expression is not dependent on p53 protein.
3.3. Speci¢city of IFN-Q-induced GKLF expression
Previous studies have shown that type I and type II IFNs
induce the expression of several common genes, but the ex-
pression of certain genes can be selectively induced by either
type I or II IFNs [22]. To examine the speci¢city of IFN-Q-
induced GKLF mRNA expression, HT-29 cells were cultured
in the presence of IFN-K or IFN-L. As shown in Fig. 4, at
concentrations of 0^1000 U/ml, neither IFN-K (Fig. 4A) nor
IFN-L (Fig. 4B) had a signi¢cant e¡ect on GKLF mRNA
levels in HT-29 cells, suggesting that IFN-Q-induced GKLF
expression is type II IFN-speci¢c. To further explore the po-
tential contribution of other serum factors on IFN-Q-induced
GKLF expression, HT-29 cells were cultured in the absence of
Fig. 2. IFN-Q induces up-regulation of GKLF mRNA and protein
levels. A: HT-29 cells were incubated with increasing concentrations
(0^400 U/ml) of IFN-Q for 24 h and total RNA was prepared and
analyzed by Northern blot as described in Section 2. B: HT-29 cells
were cultured with either medium alone (3) or with 200 U/ml IFN-
Q (+) for 0^24 h. The expression of GKLF mRNA was examined
by Northern blot analysis. To normalize the amount of loaded
RNA, the blot was stripped and hybridized with a 32P-labeled
GAPDH cDNA. C: HT-29 cells were treated with various concen-
trations (0^400 U/ml) of IFN-Q for 24 h. The GKLF and p53 pro-
tein levels were examined by Western blot analysis as described in
Section 2.
Fig. 3. GKLF mRNA expression induced by IFN-Q is independent
of p53. The 40-16 (HCT116, p53+/+) and 379.2 (HCT116, p533/3)
cells were cultured in the presence of various concentrations of
IFN-Q (0^400 U/ml) for 24 h. GKLF expression was determined by
Northern blot analysis. To con¢rm the amount of RNA loaded, the
same blot was hybridized with a GAPDH probe.
Fig. 4. Speci¢city of IFN-Q-induced GKLF expression in HT-29
cells. Cells were treated with di¡erent doses of IFN-K (A) or IFN-L
(B) (0^1000 U/ml) for 24 h, and GKLF mRNA levels were deter-
mined by Northern blot analysis. C: HT-29 cells were starved for
12 h in the serum-free medium, and then treated with IFN-Q for an
additional 24 h in the serum-free medium. Total RNA was ex-
tracted and analyzed for the presence of GKLF mRNA.
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serum for 12 h, and then treated with IFN-Q in the serum-free
medium for an additional 24 h. As shown in Fig. 4C, GKLF
mRNA levels were signi¢cantly increased in cells treated with
200 U/ml IFN-Q in the presence of serum-free medium, indi-
cating that the e¡ect of IFN-Q on GKLF expression was not
mediated through other serum factors.
3.4. IFN-Q induces GKLF mRNA expression without new
protein synthesis
To determine whether the induction of GKLF expression
by IFN-Q is dependent on de novo protein synthesis, HT-29
cells were preincubated with cycloheximide (CHX), a protein
synthesis inhibitor, and then treated with IFN-Q. As shown in
Fig. 5, CHX did not inhibit the induction of GKLF by IFN-Q.
In contrast, preincubation with CHX enhanced both basal
and IFN-Q-stimulated GKLF mRNA levels in HT-29 cells.
These results suggest that IFN-Q-induced GKLF expression
is independent of new protein synthesis, and that GKLF
may function as an immediate-early IFN-Q-responsive gene.
3.5. Kinetics of GKLF mRNA induction by IFN-Q
The kinetics of GKLF mRNA induction by IFN-Q was
examined in HT-29 cells. In response to IFN-Q (200 U/ml),
GKLF mRNA levels increased at 2 h, reached the maximal
concentration at 24 h and then gradually decreased (Fig. 6A).
The e¡ect of IFN-Q treatment on GKLF mRNA stability was
assessed by culturing HT-29 cells in the presence of IFN-Q for
24 h. Actinomycin D was then added to the medium to inhibit
the synthesis of new mRNA and total GKLF mRNA levels
were determined at di¡erent time points. As shown in Fig. 6B,
the GKLF mRNA level decreased gradually during the next
24-h period and the estimated t1=2 for GKLF mRNA turn-
over was approximately 6 h (Fig. 6C).
3.6. Overexpression of GKLF induces apoptosis in colon cancer
cells
To determine whether GKLF overexpression a¡ects the
growth and apoptosis of colon cancer cells, 40-16 (HCT116,
p53+/+), 379.2 (HCT116, p533/3), and HT-29 cells were
transiently transfected with pcDNA3/GKLF or pcDNA3
(control) for 48 h. Western blot analysis con¢rmed that cells
transfected with pcDNA3/GKLF expressed a major (60 kDa)
and a minor (30 kDa) protein (Fig. 7A), whereas very little
native GKLF protein was identi¢ed in pcDNA3-transfected
cells. Overexpression of GKLF signi¢cantly decreased cell
proliferation in all three cell lines (Fig. 7C). Moreover,
GKLF promoted apoptosis in both 40-16 and HT-29 cells
but not in 379.2 cells (Fig. 7B). Although the mechanisms
through which GKLF is involved in the induction of apopto-
sis in colon cancer cells are unknown, our results suggest that
this process may be p53-independent.
4. Discussion
IFN-Q is a cytokine produced primarily by T lymphocytes
and natural killer cells. In addition to its antiviral properties,
IFN-Q has recently been shown to be an important regulator
of cell growth, di¡erentiation, and apoptosis [11^13]. How-
ever, the mechanism(s) mediating the IFN-Q e¡ects has not
been fully elucidated. GKLF is a newly identi¢ed eukaryotic
Fig. 5. GKLF mRNA induction by IFN-Q does not require de novo
protein synthesis. HT-29 cells were preincubated with (+) or without
(3) cycloheximide (CHX) for 2 h and then treated with (+) or with-
out (3) IFN-Q for 24 h. GKLF mRNA levels in HT-29 cells were
determined by Northern blot analysis. To con¢rm the amount of
RNA loaded, the same blots were hybridized with a GAPDH
probe.
Fig. 6. Kinetics of GKLF mRNA induction by IFN-Q. (A). HT-29
cells were treated with IFN-Q (200 U/ml) and harvested sequentially
for di¡erent durations. Total RNA was extracted and GKLF ex-
pression was analyzed by Northern blot. B: The stability of GKLF
mRNA in IFN-Q-treated HT-29 cells was examined by treating cells
with IFN-Q (200 U/ml) for 24 h before the addition of actinomycin
D (10 Wg/ml). Total RNA was harvested at the indicated times and
examined for the expression of GKLF and GAPDH. C: The half-
life (t1=2) of GKLF mRNA turn-over was calculated from the above
data.
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transcription factor widely distributed in the gastrointestinal
tract [14,15]. Previous studies have shown that the expression
of GKLF is temporally associated with growth arrest of NIH
3T3 ¢broblasts [14^17]. Recent studies from our laboratory,
as presented above, have demonstrated that GKLF may play
an important role in the regulation of cell growth in the gas-
trointestinal tract [18]. The mechanisms modulating GKLF
expression have not been explored previously. In the present
study, we show that GKLF mRNA and protein levels were
low in the proliferating HT-29 cells and that IFN-Q treatment
signi¢cantly enhanced GKLF expression at both the mRNA
and protein level, suggesting that GKLF may be a down-
stream target gene of IFN-Q. Furthermore, IFN-Q treatment
in HT-29 cells reduced cell number and promoted DNA frag-
mentation, and similar e¡ects were observed in cells overex-
pressing GKLF DNA. These results suggest that up-regula-
tion of GKLF expression may play an important role in IFN-
Q-induced growth arrest and apoptosis of colon cancer cells.
In this report, we show that IFN-Q-induced up-regulation of
GKLF expression occurs rapidly (2 h after treatment) and
does not depend on de novo protein synthesis. Furthermore,
co-incubation with cycloheximide fails to suppress GKLF in-
duction and results in a further increase in GKLF mRNA
levels, indicating that one or more factors which are sensitive
to cycloheximide and are capable of a¡ecting GKLF expres-
sion may already be present in HT-29 cells. This phenomenon
is similar to what has been observed in other immediate-early
response genes [23,24], and suggests that GKLF may function
as an immediate-early IFN-Q-responsive gene. A series of im-
mediate-early IFN-Q-responsive genes including IRF-1, FcrR1,
Ly6-A/E, GBP and ICSBP have recently been identi¢ed [25^
29]. These genes share some common features, i.e. their pro-
moters contain a GAS sequence to which activated Stat 1K
can bind; and the GAS sequence is essential for their tran-
scriptional induction. Furthermore, the expression of immedi-
ate-early IFN-Q-response genes is mediated by tyrosine phos-
phorylation of the pre-existing Stat 1K, a mechanism
accounting for their rapid induction. Whether these properties
exist in the GKLF gene warrant further examination.
Mutations of the p53 gene are commonly found in various
human cancers, including colon cancer. Loss of normal p53
activity leads to uncontrolled cell growth, suggesting that p53
is a tumor suppressor gene. Although the mechanism mediat-
ing the suppressive e¡ect of p53 is not fully understood, p53
was found to bind to DNA in a sequence-speci¢c manner and
stimulated the transcription of genes downstream of the bind-
ing domains, such as p21WAF1=CIP1 [30,31]. Recently, Yang et
al. reported that wild-type p53 is necessary for the induction
of GKLF by DNA damage induced by methyl methane sul-
fonate in mouse embryo ¢broblasts [32]. In the present study,
up-regulation of GKLF expression by IFN-Q was observed
not only in HT-29 cells (p53 mutant) but also in 40-16
(HCT116, p53+/+) and 379.2 (HCT116, p533/3) cells, sug-
gesting that IFN-Q-induced GKLF expression is mediated
through a p53-independent pathway. Using a transient trans-
fection assay, we found that overexpression of GKLF reduces
cell growth in all three cell lines. However, DNA fragmenta-
tion was only observed in 40-16 and HT-29 cells, but not in
379.2 cells. These results provide evidence that the growth
arrest and apoptosis induced by GKLF in colon cancer cells
may be mediated through a di¡erent pathway. Further inves-
tigation will be required to elucidate their mechanisms.
Previous studies have shown that type I and II IFNs induce
the expression of several common genes, whereas the expres-
sion of certain genes is modulated di¡erentially by the type I
or II IFNs [22,25]. These e¡ects may account for the similar
Fig. 7. Overexpression of GKLF induced growth arrest and promoted apoptosis. A: The 379.2, 40-16 and HT-29 cells were transiently trans-
fected with pcDNA3-GKLF or pcDNA3 (control) cDNA. Total protein was harvested at 48 h and examined for the expression of GKLF.
B: Transfected cells were harvested to examine for the presence of fragmented DNA as described in Section 2. C: Cells were transfected with
GKLF or pcDNA3 (control) cDNA, and cell numbers were determined 48 h later. Each data point represents mean þ S.E.M. of three separate
experiments. *P6 0.05 compared to pcDNA3-transfected cells.
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and di¡erent biological properties shared by two IFNs. In this
report, we show that the induction of GKLF mRNA expres-
sion by IFN-Q is speci¢c to type II interferon, as no signi¢cant
change in GKLF mRNA level was observed in cells treated
with IFN-K or -L. These data suggest that GKLF is a down-
stream target of IFN-Q that mediates its unique functions in-
cluding growth arrest and apoptosis in the colon cancer cells.
In summary, the results of this study demonstrate that IFN-
Q induced GKLF gene expression in HT-29 cells in a dose-
dependent and time-dependent manners. This induction is
rapid, p53-independent, and does not require de novo protein
synthesis suggesting that GKLF is an immediate-early IFN-Q-
responsive gene. Overexpression of GKLF in colon cancer
cells induces similar e¡ects as IFN-Q indicating that GKLF
is the downstream target of IFN-Q. These data and our pre-
vious report [18] suggest that GKLF may play an important
role in the physiological cell renewal by inducing cell prolif-
eration, di¡erentiation and cell death through apoptosis in the
non-neoplastic colonic mucosa as well as in cancer cells.
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